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Abstract 
Objectives: To evaluate the effectiveness of beta tricalcium phosphate (β-TCP) alone compared to β-TCP and De-
mineralized Bone Matrix (DBM) in regenerating localized horizontal maxillary alveolar ridge deficiencies prior to 
implant placement.
Study Design: The study included 20 patients with horizontal maxillary ridge deficiencies limited to one or more 
neighbouring teeth and initial ridge width of ≤ 5mmm. Patients were divided equally into two equal groups. Ridge 
augmentation was performed using Guided Bone Regeneration (GBR) principals. In group I GBR was performed 
using β-TCP only, while in group II both β-TCP and DBM were used. Following a 6 months healing period, bone 
cores from both groups were retrieved and implants were inserted. Specimens were examined histologically to cal-
culate percentage of mineralized bone. Apical and crestal changes in ridge dimensions were calculated by digital 
subtraction using Cone Beam Computed Tomography (CBCT) immediately after graft placement and six months 
later.
Results: There was a statistically significant difference between the mean area percentage of mineralized bone bet-
ween both groups where it was 40.1 % (range: 27.76-% 66.29 %) for group I and 68.96 % (range: 60.07 % - 87.33 
%) for group II. Radiograpically, the mean ridge width in group I increased crestally to 4.66 mm (range:3.5-5mm) 
and apically to 6.12 mm (range: 4.1-6.7 mm). In group II the mean ridge width increased crestally to 5.2 mm (range 
4.9-5.4mm) and apically to 6.9 mm (range 6.0-7.8 mm). Group II showed more bone gain with a mean of 1.37 mm 
crestally and 2.44 mm apically. This difference however was not statistically significant
Conclusion: Within the limitations of this study the combination of DBM and β-TCP can be used effectively in 
cases exhibiting minimal alveolar ridge defects. 
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Introduction
Alveolar bone loss can occur after tooth extraction, trau-
ma, as a result of advanced periodontal disease or failed 
endodontic therapy (1). If the alveolar ridge is not pre-
served at the time of tooth extraction or loss, alveolar 
ridge height and width may be lost, particularly in the 
area of the facial plate. Several system reviews have re-
ported losses between 3 & 6 mm horizontally and 2 mm 
vertically (2).
An essential condition for successful implant therapy is 
the presence of an adequate quantity and quality of bone. 
A significant problem, however, is insufficient height 
and width of the alveolar bone at the implantation site 
(3). Several methods have been developed to augment 
the deficient bone volume. These include Guided Bone 
Regeneration (GBR) with barrier membranes, onlay 
bone grafting, ridge splitting and distraction osteogensis 
(4). 
Although the use of autogenous bone has been widely 
accepted as the gold standard augmentation material; 
intra- and extra-oral donor site morbidity, potential com-
plications and risks associated with the harvesting pro-
cedures have been reported. Because of these drawbacks 
most recent GBR research has focused on augmentation 
procedures using bone substitution materials of alloge-
nic, alloplastic, or xenogenic origin in combination with 
barrier membranes (5).
Cerasorb M® represents a new generation of pure pha-
se beta tricalcium phosphate (β-TCP). The material is 
highly biocompatible and provides a unique intercon-
necting scaffold that allows it to be completely resorbed 
while simultaneously facilitating new bone formation 
(6). The material is sintered prior to packaging and has 
an intragranular porosity of 65%. This granulates (po-
lygonal morsals) have a particle size ranging from 150-
500um and 500-1000um (7).  With its consistent poro-
sity and calcium phosphate ratio, the material provides 
predictable resorption and new bone formation within 
4-12 months. The capillary effect of the blood within 
Cerasorb M ® granules promotes the rapid formation of 
osteoblasts which stimulates vital bone growth (8).
Activagen ® (Osteoplant activagen ®, Biotek, Italy) is 
a material composed of lyophilized granules of type I 
collagen prepared from a xenogenic equine source and 
has been described as an activator of morphogenesis. 
The product is prepared by enzymatic deantigenation of 
equine femurs bones. The process eliminates all the or-
ganic components of bone (proteins, lipids & sugars) ex-
cept collagen type I .As the material becomes implanted 
in the graft site, it undergoes degradation in the presence 
of osteoclasts. The lyophilized protein factors become 
released, undergo hydration and, are able to exercise the 
morphogenetic effect on the undifferentiated mesenchy-
mal cell elements, inducing their differentiation into os-
teoblasts leading to the formation of new bone tissue (9).
Material and Methods
- Patients’ selection 
20 patients (12 females and 8 males), age range from 18 
years to 45 years (average 31.5 years) underwent GBR 
using non-resorbable barrier membranes, followed by 
implant placement after six months. All patients had lo-
calized horizontal alveolar ridge deficiency, limited to 
one or two neighbouring teeth, with an initial ridge wi-
dth of ≤ 5 mm. and 21 potential implant sites. This was 
determined pre-operatively using a ridge mapping cali-
ber (Oraltronics, Bremen, Germany), and Cone Beam 
Computed Tomograhy (CBCT). Subjects with medical 
conditions or lifestyle factors likely to affect healing 
were excluded from the study, including those with un-
controlled diabetes, immune disease, history of alcohol 
or drug abuse, current smokers, or individuals deemed 
to be a compliance risk.The protocol of this study was 
approved by the Ethical Committee of the National Re-
search Center, Egypt. The selected patients were divided 
into two equal groups; Group I , where GBR was per-
formed using β-TCP, (Cerasorb M ®,Cursan AG, Ger-
many), and group II where Cerasorb M ®, was mixed 
with DBM (Osteoplant activagen ®, Biotek, Italy) in a 
1:1 ratio according to the manufacturer recommenda-
tions.
- Surgical and grafting procedure
All patients received prophylactic antibiotic (1 gm. 
Amoxicillin-clavulanate, Augmentin ®, GlaxoSmithKli-
ne, UK) one hour preoperatively and then every twelve 
hours for four days and were instructed to rinse with 
0.12% Chlorhexidine gluconate (Lysoplaque ®, Fran-
ce) for one minute prior to surgery and twice daily for 2 
weeks postoperatively. All procedures were performed 
under local anathesia utilizing articaine hydrocholoride 
4% with 1:100000 epinephrine (Septanest®, Septodont, 
USA). Full thickness periosteal flaps were elevated. A 
drill was used to make a channel in the deepest part of 
the bony defect to anchor a 1.3 mm micro bone screw 
(Biomet microfixation, Florida, USA).
Following screw insertion the bone surface was decor-
ticated to stimulate bleeding from the marrow com-
partment. In group I the β-TCP was prepared according 
to the manufacturer’s recommendations where it was 
mixed with the patient’s own blood. For patients in 
group II both the β-TCP and DBM were mixed together 
before adding the patient’s blood. Following adapta-
tion of the graft material, a high density poly-tetraflu-
roethyelene membrane (Cytoplast GBR-200, Oraltro-
nics, Bremen,Germany) was applied and fixed in place 
using titanium bone tacks (Dentium, Seoul, S. Korea). 
The flaps were adjusted using periosteal releasing inci-
sions to provide tension free closure and flaps were sutu-
red using 3-0 silk sutures (Ethicon, Johnson & Johnson, 
France). 
Augmentin (1gm tablets) was prescribed for the patients 
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cron thickness and mounted on glass slides. The sections 
were de-paraffinized, hydrated, and stained with haema-
toxylin and eosin.
Sections were examined with (10X magnification) using 
Olympus CX20 microscope (Olympus Europa Holding 
GmbH, Hamburg), attached to a camera and computer. 
All the stained sections were examined by image analy-
zer computer system using the ImageJ software (NIH, 
version v1.45e, USA) capable of performing high speed 
digital image processing for the purpose of tissue mea-
surements.Image J software was calibrated and the ima-
ges were opened on the computer screen for pre-analysis 
adjustments.
Histomorphometric measurements were used to quanti-
fy the relative amounts of different tissue types within 
the grafted area. The following variables were measu-
red: area percentage of mineralized bone and area per-
centage of remaining graft particles when found. Mean 
values for histomorphometric variables were calculated 
for each group. For histomorphometric analysis of the 
area percent of bone, the color of bone trabeculae was 
automatically selected, converted into grey then masked 
by a red color which allowed automatic measurement by 
the computer system. (Fig. 1,2).
to be taken regularly every 12 hours for 4 days.  Diclo-
fenac Sodium 75 mg intramuscular injection (Voltaren, 
Novartis, Switzerland) was given every 12 hours for the 
first 48 hours and then was replaced with 50 mg enteric 
coated tablets taken only when needed. Patients were 
instructed to rinse with 0.12% Chlorohexidine glucona-
te 3 times per day for two weeks. Sutures were removed 
15 days following the surgery. Patients were followed 
up for signs and symptoms of pain, inflammation, infec-
tion, wound dehiscence or membrane exposure 24 hours 
postoperatively, then day after day for the first week, and 
then monthly for 6 months.
- Radiographic Evaluation
An immediate CB CT scan was taken for each patient 
to serve as a reference point for future measurements. 
Following a six months healing period, another CBCT 
scan was performed to evaluate the outcomes of the re-
generation process. 
Analysis of the changes in ridge width was made on both 
the CBCT software and image J software. CBCT images 
of the area of interest were generated by redrawing the 
dental arches using identical reference points. After ge-
nerating the panoramic view, Serial cuts of 1.5 mm thic-
kness were obtained in the sagittal plan. Pre and post-
operative images having the same reference number of 
bony cut were then selected. For each case; the initial 
CBCT scan and the corresponding 6 CBCT scan were 
superimposed using Image J software and the amount of 
change at the crest and 10 mm apical to the crest were 
calculated by digital subtraction 
- Sample Collection and Implant Procedure
Following 6 months healing period, a flab was elevated 
the membrane and tentative screw were removed and the 
area was irrigated was copious saline. A bone core biop-
sy was taken from the implant sites with a 2 mm diame-
ter trephine drill (Hu-Friedy, USA). The osteotomy was 
further enlarged using twist drills, following the regular 
sequence of drilling recommended by the manufacturer 
and a suitable implant  (Screwplant, Implant direct LLC, 
USA)  was screwed in position to the desired depth. Fix-
tures were covered with the covering screw followed 
by copious amount of irrigation and the flaps were re-
approximated using tension-free interrupted sutures and 
post-operative instructions were given
- Histomorphometric analysis 
Bone biopsies were fixed in 10% neutral buffered for-
maldehyde for two weeks. Specimens were decalcified 
in Ethylene Dimethyl Tetra Acetic Acid (EDTA). The 
solution was changed daily for one week. Decalcifica-
tion was considered complete when the specimens rea-
ched a rubber like consistency. The specimens were then 
dehydrated in ascending grades of alcohol (50%, 75%, 
and 100%), cleared in xyline and then embedded in pa-
raffin. The paraffin-embedded specimens were serially 
cut in a cross sectional plane into sections of five mi-
Fig 1. Histogram demonstrating the mean bone gain of ridge width 
apically and crestally for Group I and Group II.
Fig. 2. Histogram showing the mean area percentage of mineralized 
bone and remaining graft material in Group I and Group II.
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- Statistical Analysis
Statistical analysis was performed using SPSS (Statisti-
cal package for the social sciences) (version 15, Echosoft 
Corp, U.S.A.) Data were represented as mean ± standard 
deviation. Paired sample student t-test was used to com-
pare each pair of the studied variables within the studied 
group of patients. Independent sample t-test was used to 
compare variables between the two studied groups. The 
test result was considered statistically significant if the P 
value was equal to or less than 0.05.
Results
- Clinical Findings
One case from each group demonstrated early exposure 
of the barrier membrane which required their removal 
after four weeks leaving only 18 patients with 19 poten-
tial implant sites. All remaining cases healed uneventfu-
lly without any serious adverse effects and demonstrated 
clinically significant increase in alveolar ridge width, 
and resistance to drilling when the implant bed was be-
ing prepared.
- Histological findings 
In group I, the remaining graft material was seen as 
spherical structures with various forms and sizes. Mi-
neralized bone was seen between and surrounding the 
remaining graft particles. Evidence of osteoblastic rim-
ming and   osteoid tissue having viable osteocytes were 
seen in close proximity to the mineralized bone sugges-
ting active bone formation.The general findings showed 
evidence of remodeling and new bone surrounding the 
graft fragments. In group II, large amounts of minerali-
zed bone tissue with minimal traces of the graft material 
surrounded by newly formed bone tissue were consis-
tently seen. Evidence of osteoblastic rimming and osteo-
id tissue were seen in close proximity to the mineralized 
bone suggesting active bone formation .
Statistical analysis
- Histologically
Analysis of the histological sections demonstrated that 
the mean area percentage of mineralized bone was 40.1 
% (range: 27.76-% 66.29 %) for group I and 68.96 % 
(range: 60.07 % - 87.33 %) for group II. The mean area 
percentage of remaining β-TCP was 6.5 % (range: 3.36 
-10.63 %) for group I and 1.7 % (range: 0.15%- 4.5 %) 
for group II (Table 1).  There was a statistically signi-
ficant difference between both groups, where group II 
had a higher area percentage of mineralized bone and a 
smaller area percentage of the remaining graft material 
than group I (Table 2).
Table 1. Means and standard deviations for the area percentage of mineralized bone and remaining graft material in Group 
I and Group II.
Minimum % Maximum % Mean % SD
Group I Group II Group I Group II Group I Group II Group I Group II
Percentage of mineralized 
bone area 27.76 60.07 66.29 87.33 40.1 68.96 +15.3 +10.59
Percentage of remaining 
graft material 3.36 0.15 10.63 4.5 6.52 1.73 +2.87 +1.74
Table 2. Comparison between the mean area percentage of minerali-
zed bone and remaining graft material of Group I & that of Group II.
Group I Group II
P-value
Mean SD Mean SD
Percentage of min-
eralized bone area 40.1 +15.38 68.96 +10.59 0.009*
Percentage of re-
maining material 6.52 +2.87 1.73 +1.74 0.013*
*: Significant at P ≤ 0.05
- Radiographically
For group I, the mean ridge width apically in the initial 
CBCT was 4.1 mm (range: 2.0-3.6 mm), while crestally 
it was 3.44 mm (range: 1.7-5mm). Analysis of the CBCT 
scan taken 6 months later showed that the mean ridge 
width apically increased to 6.12 mm (range: 4.1-6.7 
mm) and crestally to 4.66 (range: 3.5-5 mm) (Table 3). 
In group II, the mean ridge width apically in the initial 
CBCT was 4.5 mm (range 3.8-5mm), while crestally it 
was 3.8 mm (range 3.3-4.3mm). Postoperative analysis 
of the CBCT scan 6 months later showed that the mean 
ridge width apically was increased to 6.9 mm (range 
Crestally Apically
Group I Group II Group I Group II
Mean SD Mean SD Mean SD Mean SD
Initial ridge width 3.44 +0.4 3.83 +0.51 4.15 +1.57 4.58 +0.53
Ridge width after 6 
months 4.66 +0.75 5.21 +0.21 6.12 +1.33 6.9 +1.49
P value 0.006* 0.004* 0.001* 0.001*
*: Significant at P ≤ 0.05
Table 3.  Means and Standard deviations for the alveolar ridge widths (initial and 6 months later) in Group I and II. 
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6.0-7.8 mm) and crestally to 5.2 mm (range 4.9-5.4mm) 
(Table 3).
The amount of bone gain both apically and crestally was 
statistically significant for both groups. Although group 
II showed more bone gain with a mean of 1.37 mm cres-
tally and 2.44 mm apically, this difference was not sta-
tistically significant (Table 4).
with the remaining β–TCP granules  suggesting that the-
se granules attract osteoprogenitor cells that migrate into 
the micropores of the graft material . Histological results 
of both groups demonstrating minimal traces of β-TCP 
are in accordance with those of other studies which have 
shown that the material can be replaced completely by 
new bone within a six months healing period (18, 19 ).
Results of this study demonstrated higher percentage of 
new bone formation and lesser percentage of remaining 
graft material in group II than group I. This is in agree-
ment with the histomorphemetric analysis of a previous 
study that showed that the rate of breakdown of the graft 
material was proportional to the amount of new bone 
regeneration (20).
DBM has been shown to induce osteoblastic differen-
tiation and proliferation of bone marrow mesenchymal 
stem cells. Histologic evidence of osteoblasts penetrating 
the surface of the DBM granules denoted the material’s 
ability to support osteoblastic cell adhesion (21). Results 
showed that the density of the newly formed bone inside 
surgically created gaps filled with DBM reached 93% 
of native bone density after 12 weeks (22). Moreover 
radiographic evidence of new bone formation after using 
injectable DBM during sinus elevation surgery was seen 
following a 6 months healing period (23).
With the material’s ability to induce differentiation of 
mesenchymal cells to form bone as well as serve as a 
scaffold for osteoprogenitor cells attachment (22,24,25), 
the combined effect of adding both DBM and β-TCP to 
augment the deficient horizontal alveolar ridge was eva-
luated in this study.
To our knowledge no other human studies compared the 
effect of using of β-TCP alone versus β-TCP and DBM 
in regenerating alveolar ridge deficiencies.
One study evaluated the osteogenic activity of β-TCP 
and DBM in a rabbit model, where osseous defects were 
surgically created on the right and left edentulous rid-
ges of the mandibles and one side filled with the DBM 
and the other with β-TCP. Histological results showed 
that by the end of the 6 week mature bone tissue had 
completely filled the defects. The DBM was completely 
resorbed at 5 weeks; however remnants of the β-TCP 
were still present (25). In contrast to these findings ano-
ther research used DBM for regenerating dehiscence 
defects around dental implants and found that remnants 
of the material were still present six months following 
grafting. However the authors were able to demonstrate 
that new bone formation and graft resorption occurred 
as healing progressed (26). When comparing the histolo-
gical results for both groups it was found that there was 
a statistically significant difference between the amount 
of mineralized bone and remnants of the graft material 
in group II (68.9% & 1.2 % respectively) compared to 
group I (40.1% & 6.5%) (26).
For all patients in both groups there was a significant 
Table 4. Comparison between the bone gain apically and crestally of 
Group I and that of Group II.
Group I Group II
P Value
Mean SD Mean SD
Crestal bone gain 1.22 +0.35 1.37 +0.35 0.697
Apical bone gain 1.96 +0.25 2.44 +0.34 0.583
*: Significant at P ≤ 0.05
Discussion
This study evaluated the radiographic and histologi-
cal outcomes of localized ridge augmentation utilizing 
DBM of equine origin (Activagen)® combined with 
β–TCP (Cerasorb M)® compared to β–TCP alone. Non 
resorbable barrier membranes were chosen owing to 
their better space-maintaining abilities, controlled time 
of barrier function, lack of a resorption process and hig-
her percentage of bone regeneration that can be achieved 
with their use compared to resorbable barriers (10).
One case in each group experienced failure of the bone 
graft to augment the alveolar ridge to an ideal dimension 
suitable for implant placement. This was due to dehis-
cence of the flaps and exposure of the membranes which 
required their early removal. Several studies have de-
monstrated membrane exposure to be the most common 
postoperative complication following GBR (11,12).
One of the possible causes for early membrane exposure 
could be attributed to necrosis of a thin flap covering the 
membrane. In GBR, blood supply to the flaps depends 
on flap thickness because blood supply from the bone 
to the flap is impeded by the membrane (13).Another 
possible cause for early membrane exposure could be 
insufficient release of horizontal periosteal incisions of 
the buccal flap that led to tension and subsequent ische-
mia of the tissues at the suture line. In order to prevent 
this it was recommended that the buccal and lingual/pa-
latal flaps should overlap by at least 10 mm to obtain a 
tension-free closure (14).
Cerasorb M was chosen for horizontal ridge augmenta-
tion owing to its biocompatibility and satisfactory en-
hancement of bone regeneration as reported by several 
studies (15,16).
In the present study mineralized bone was seen between 
and surrounding the remaining graft particles with evi-
dence of osteoblastic rimming in close proximity to the 
mineral bone suggesting active bone formation. The 
results are in accordance with previous reports (17, 8 ) 
where bone and osteoid tissue were seen lying in contact 
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increase in ridge width along its entire length, relative to 
the pre-surgical values of each group. Although the gain 
in ridge width measured on the CBCT for group II was 
found to be more than in the control, the difference was 
not found to be statistically significant when both groups 
were compared.
Bone formation in grafts is thought to occur via three 
mechanisms of bone deposition: 1) Osteogenesis, oste-
oinduction, and osteoconduction, in which the graft acts 
as a scaffold for deposition of new bone by adjacent li-
ving bone (27). β-TCP bone substitute used in this study 
works by osteoconduction, i.e. by guiding osteogenic 
cells from existing bone. These osteogenic cells diffe-
rentiate into osteoblasts, which form bone between the 
separate graft particles (34).
DBM works through both osteoinduction and osteocon-
duction. The material induces osteoblasts’ and chondro-
blasts’ differentiation from mesenchymal cells. With its 
osteoinductive properties DBM leads to an increase in 
the number of available osteoblasts at the graft site (26). 
The presence of β-TCP which supports osteoblasts ad-
hesion (28), combined with DBM at the defect site, can 
explain the higher percentage of mineralized bone that 
was found in the test group and more bone gain that was 
measured radiographically. 
The outcome of this study is comparable to former stu-
dies that used xenografts alone or in combination with 
allogenic DBM to regenerate horizontal ridge defects. 
These results are also in agreement with evidence from 
the literature that both materials have the ability to su-
pport new bone formation (29,30).
Conclusion
GBR using d-PTFE membranes and an alloplast (β-TCP) 
can result in successful horizontal ridge augmentation 
sufficient for placement of endosseous implants. Com-
bining both β-TCP with DBM can further enhance the 
amount of bone gain in the defect area. Further investi-
gations and a larger study sample are required to verify 
the outcomes of this research..
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